Ko YH - Search Results

1

Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma.

Lee YP, Yoon SE, Cho J, Ko YH, Oh D, Ahn YC, Kim WS, Kim SJ. Lee YP, et al. Among authors: ko yh. Cancer Manag Res. 2023 Jun 5;15:463-474. doi: 10.2147/CMAR.S407837. eCollection 2023. Cancer Manag Res. 2023. PMID: 37304895 Free PMC article.

2

REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.

Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR. Ko YH, et al. Cancer. 1998 Aug 15;83(4):806-12. Cancer. 1998. PMID: 9708949

3

Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.

Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS, Kim SW. Ko YH, et al. Cancer. 2000 Nov 15;89(10):2106-16. doi: 10.1002/1097-0142(20001115)89:10<2106::aid-cncr11>3.0.co;2-g. Cancer. 2000. PMID: 11066052

4

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY, Yoon SS, Lee HG, Kang WK, Lee HJ, Park CH, Park K. Kim WS, et al. Among authors: ko yh. Ann Oncol. 2001 Mar;12(3):349-52. doi: 10.1023/a:1011144911781. Ann Oncol. 2001. PMID: 11332147 Free article.

5

Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma.

Park W, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO. Park W, et al. Among authors: ko yh. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1480-6. doi: 10.1016/j.ijrobp.2003.09.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050327

6

Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment.

Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, Chun HK, Lee WY, Park JO, Jung CW, Im YH, Lee MH, Kang WK, Park K. Lee J, et al. Among authors: ko yh. Leuk Lymphoma. 2004 Feb;45(2):339-44. doi: 10.1080/10428190310001593111. Leuk Lymphoma. 2004. PMID: 15101721

7

Primary pulmonary non-Hodgkin's lymphoma.

Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K, Han JH, Ko YH. Kim JH, et al. Among authors: ko yh. Jpn J Clin Oncol. 2004 Sep;34(9):510-4. doi: 10.1093/jjco/hyh095. Jpn J Clin Oncol. 2004. PMID: 15466823

8

Nasal-type NK/T cell lymphoma: clinical features and treatment outcome.

Lee J, Kim WS, Park YH, Park SH, Park KW, Kang JH, Lee SS, Lee SI, Lee SH, Kim K, Jung CW, Ahn YC, Ko YH, Park K. Lee J, et al. Among authors: ko yh. Br J Cancer. 2005 Apr 11;92(7):1226-30. doi: 10.1038/sj.bjc.6602502. Br J Cancer. 2005. PMID: 15798768 Free PMC article.

9

The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.

Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, Lee SS, Lee SI, Koo HH, Kim WS. Kwon JM, et al. Among authors: ko yh. Ann Hematol. 2006 Jul;85(7):463-8. doi: 10.1007/s00277-006-0081-9. Epub 2006 Mar 14. Ann Hematol. 2006. PMID: 16534596

10

Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1.

Kim JH, Kim WS, Kang JH, Lim HY, Ko YH, Park C. Kim JH, et al. Among authors: ko yh. FEBS Lett. 2007 Feb 20;581(4):623-8. doi: 10.1016/j.febslet.2007.01.020. Epub 2007 Jan 18. FEBS Lett. 2007. PMID: 17257596 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,054 results

Search Page